HRS/HRS-2 Polyclonal Antibody

Description:

Polyclonal Antibodies Against HRS

The Technology: Dr. Andrew Bean at the University of Texas Health Science Center at Houston (UTHealth) has developed a polyclonal antibody to Hrs. Hrs is a protein that plays a role in the growth factor signaling pathways. Cellular expression of hrs-2 can be determined via the polyclonal Hrs antibody. This antibody will be useful in determining the relationship between growth factor receptor tyrosine kinases and tyrosine phosphorylation of Hrs.

Publications:
• Growth factor-induced tyrosine phosphorylation of Hrs, a novel 115-kilodalton protein with a structurally conserved putative zinc finger domain. Mol Cell Biol. 1995 Nov;15(11):6213-21.


 

UTHealth Ref. No.: 2002-0010
Inventors: Andrew Bean
License Available: world-wide; non-exclusive

Patent Information:

The preceding is intended to be a non-confidential and limited description of a novel technology created at the University of Texas Health Science Center at Houston (UTHealth). This promotional material is not comprehensive in scope and should not replace company’s diligence in a thorough evaluation of the technology. Please contact the Office of Technology Management for more information regarding this technology.
Category(s):
Research Materials
For Information, Contact:
Danielle Martinez
Technology Licensing Associate
University of Texas Health Science Center At Houston
danielle.r.martinez@uth.tmc.edu
Inventors:
Keywords:
© 2020. All Rights Reserved. Powered by Inteum